• Busca personas
• Intranet

Neuroimagen de trastornos mentales Òscar Vilarroya

Publicaciones 2023 (4)

• Toll A, Blanco-Hinojo L, Bergé D, Martin-Subero M, Casanovas F, El-Abidi K, Pérez V, Mané A^*. Higher lymphocyte count associated with larger hippocampal volume and fewer depressive symptoms in drug-na ïve first-episode psychosis. Eur Neuropsychopharmacol 2023; 69: 47-55 (en Premsa).
• Valli I^*, Gonzalez-Segura À, Verdolini N, Garcia-Rizo C^*, Bergé D, Baeza I, Cuesta MJ, González Pinto A, Lobo A, Martínez-Arán A, Mezquida G, Pina-Camacho L, Roldán-Bejarano A, Mas S, McGuire P, Bernardo M, Vieta E, PEPs group. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis. Acta Psychiatr Scand 2023: (en Premsa).
• Corcoles D, Ramos-Perdigues S, González-Fresnedo AM, Bellsola M, Malagón-Amor A, Martín LM. Verbal de-escalation to reduce the use of mechanical restraint during nonvoluntary ambulance transfers. Emergencias 2023; 35(2): 97-102.
• Barrera M, Veza E, Gomis-González M, Garcia-Quintana J, Trabsa A, Martinez-Sadurni L, Pujadas-Bastardes M, Pérez V, de la Torre R, Bergé D, Robledo P^*. Role of cyclin-dependent kinase 5 in psychosis and the modulatory effects of cannabinoids. Neurobiol Dis 2023; 176: 105942.